OWP
TYRA icon

Old Well Partners’s Tyra Biosciences TYRA Stock Holding History

Old Well Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,500
Closed -$148K – 44
2021
Q4 		$148K Buy
+10,500
New +$209K 0.09% 33

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Old Well Partners's TYRA Position: Q1 2022 in Review

Old Well Partners sold out of Tyra Biosciences (TYRA) in Q1 2022, closing a stake of 10,500 shares — an estimated $148K sold.

Old Well Partners first reported a position in TYRA in Q4 2021 and held it in 1 quarter. The position peaked at $148K in Q4 2021. 46 funds tracked by Wall St. Rank hold TYRA as of Q1 2022.

  • Old Well Partners reported no remaining Tyra Biosciences position as of Q1 2022 after selling out during the quarter.
  • Old Well Partners sold 10,500 Tyra Biosciences shares in Q1 2022, an estimated $148K.
  • Old Well Partners first reported a position in Tyra Biosciences in Q4 2021 and held it in 1 quarter.
  • Old Well Partners's Tyra Biosciences position peaked at $148K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2022.

Based on Old Well Partners's 13F filing for Q1 2022, filed 16 May 2022.